| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | D H Char | |
| P2860 | cites work | Muscle autoantigens in thyroid associated ophthalmopathy: the limits of molecular genetics | Q28255900 |
| A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy | Q28285681 | ||
| Intrathyroidal activated (Ia+) T-lymphocyte CD+ subsets and B cells in Graves' hyperthyroidism respond rapidly to propylthiouracil therapy: demonstration using fine needle aspirates and two-colour laser flow cytometry | Q33192145 | ||
| Is endocrine ophthalmopathy related to smoking? | Q34085245 | ||
| The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota | Q34164149 | ||
| Thyroid-stimulating antibody activity between different immunoglobulin G subclasses | Q34260056 | ||
| Molecular cloning of the thyrotropin receptor | Q34457109 | ||
| Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy | Q35837567 | ||
| Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism | Q35837670 | ||
| Nature of 64 kDa eye muscle and thyroid membrane proteins and their significance in thyroid-associated ophthalmopathy--an hypothesis. | Q36749737 | ||
| T cell responses to orbital antigens in thyroid-associated ophthalmopathy | Q36750510 | ||
| Antibodies against 1D, a recombinant 64-kDa membrane protein, are associated with ophthalmopathy in patients with thyroid autoimmunity. | Q36763194 | ||
| Lack of evidence supporting the presence of mRNA for the thyrotropin receptor in extra-ocular muscle | Q36763958 | ||
| Has the use of antithyroid drugs for Graves' disease become obsolete? | Q39232945 | ||
| Graves' ophthalmopathy: current concepts regarding pathogenesis and management | Q39489563 | ||
| Medical Management of Graves' Ophthalmopathy | Q40426007 | ||
| Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy | Q40459843 | ||
| Early complications of radioiodine treatment for hyperthyroidism | Q72539834 | ||
| Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists | Q72754868 | ||
| Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic | Q72800952 | ||
| The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease | Q72812221 | ||
| Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease | Q72865652 | ||
| The ocular muscle cell is a target of the immune system in endocrine ophthalmopathy | Q40611924 | ||
| The fibroblast is the target cell in the connective tissue manifestations of Graves' disease | Q40611928 | ||
| Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review | Q40864701 | ||
| Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. | Q41222380 | ||
| Cross-reactive antibodies in the serum of balb/c mice immunized with thyroid or eye muscle membranes. | Q41492499 | ||
| Dysthyroid Ophthalmopathy in Children | Q41690731 | ||
| Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy | Q42505130 | ||
| Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism | Q43907362 | ||
| The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine. | Q44402083 | ||
| More on smoking habits and Graves' ophthalmopathy | Q44906164 | ||
| Detection, cellular localization, and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves' disease | Q45066436 | ||
| Treatment of Graves' disease and the course of ophthalmopathy | Q45235961 | ||
| Soluble IL-2 receptor levels in patients with Graves'ophthalmopathy | Q45907831 | ||
| Graves exophthalmos unrelated to extraocular muscle enlargement. Superior rectus muscle inflammation may induce venous obstruction | Q46504912 | ||
| A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves' thyroid and ophthalmic diseases | Q48619925 | ||
| Orbital fat removal. Decompression for Graves orbitopathy. | Q51664950 | ||
| Comparison of RA 131I treatment protocols for Graves' disease. | Q53712862 | ||
| Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism | Q57482592 | ||
| Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts | Q67522831 | ||
| Evidence for the presence of a functional TSH-receptor in retroocular fibroblasts from patients with Graves' ophthalmopathy | Q67525033 | ||
| Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies | Q67526378 | ||
| Regulation by glucocorticoids of interferon gamma-induced HLA-DR antigen expression in cultured human orbital fibroblasts | Q67574105 | ||
| Association between Graves' ophthalmopathy and smoking | Q68088136 | ||
| Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin | Q68095029 | ||
| The ophthalmopathy of Graves' disease | Q68182223 | ||
| Effect of growth factors on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts of Graves' ophthalmopathy in culture | Q68231114 | ||
| Prognostic factors in the radiotherapy of Graves' ophthalmopathy | Q68353384 | ||
| A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy | Q68488678 | ||
| Medical approach to ophthalmopathy of Graves' disease | Q68769780 | ||
| Re-evaluation of eye muscle autoantibody determination in Graves' ophthalmopathy: failure to detect a specific antigen by use of enzyme-linked immunosorbent assay, indirect immunofluorescence, and immunoblotting techniques | Q69116314 | ||
| Phorbol ester-induced orbital myositis | Q69265979 | ||
| Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy | Q69288448 | ||
| Ophthalmopathy and thyroid stimulation | Q69373946 | ||
| Clinical presentation of Graves' ophthalmopathy | Q69739877 | ||
| Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator | Q70080921 | ||
| Orbital Cobalt Irradiation Combined with Systemic Corticosteroids for Graves' Ophthalmopathy: Comparison with Systemic Corticosteroids Alone* | Q70251349 | ||
| Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study | Q70321449 | ||
| Pathogenesis of Graves' ophthalmopathy | Q70513409 | ||
| Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy | Q70587767 | ||
| Glucocorticoids modulate the synthesis and expression of a 72 kDa heat shock protein in cultured Graves' retroocular fibroblasts | Q70594904 | ||
| Graves' disease, endocrine ophthalmopathy and smoking | Q70605949 | ||
| Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug | Q70812554 | ||
| Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy | Q71616312 | ||
| Endocrine ophthalmomyopathy in adolescence | Q71859170 | ||
| Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy | Q72019202 | ||
| Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy | Q72066466 | ||
| Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue | Q72226506 | ||
| The site of the autoantigen in dysthyroid eye disease: a significant negative | Q72271164 | ||
| Color duplex ultrasound findings in patients with endocrine orbitopathy | Q72397964 | ||
| Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? | Q72414211 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 922-926 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | British Journal of Ophthalmology | Q13443571 |
| P1476 | title | Thyroid eye disease | |
| P478 | volume | 80 |
| Q33597076 | Acetazolamide and Thyroid-Associated Ophthalmopathy; a Preliminary Tested Hypothesis in a TertiaryReferral Center |
| Q73870904 | Antioxidant agents in the treatment of Graves' ophthalmopathy |
| Q74216894 | Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease |
| Q47685471 | Proteomic analysis of the differences in orbital protein expression in thyroid orbitopathy. |
| Q35314277 | T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy |
| Q39303459 | The effect of orbital radiation therapy on thyroid-associated orbitopathy complicated with dysthyroid optic neuropathy |
| Q41734163 | Treating severe Graves' ophthalmopathy |
Search more.